- Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. Dae Won Park; Jang Wook Sohn; Hee Jin Cheong; Woo Joo Kim; Min Ja Kim; Je Hyeong Kim; Chol Shin // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p26
Background: The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement. Amphotericin B is more frequently used as initial therapy if the patient's...
- Coccidioidomycosis in adolescents with lupus nephritis. Yorgin, Peter D.; Rewari, Mona; Al-Uzri, Amira Y.; Theodorou, Andreas A.; Scott, Katherine M.; Barton, Leslie L. // Pediatric Nephrology;2001, Vol. 16 Issue 1, p77
Coccidioidomycosis, a fungal infection endemic in the southwestern United States, can cause life-threatening infections in immunosuppressed patients. We report the contrasting cases of two adolescents with lupus nephritis, treated with intravenous pulse cyclophosphamide and daily oral...
- San Joaquin valley fever. // Taber's Cyclopedic Medical Dictionary;2005, p1942
The article presents a definition for the term "San Joaquin valley fever," which refers to an infectious disease similar to that of coccidioidomycosis.
- Chapter 2 - Coccidioidomycosis. Filho, Antõnio de Deus // Jornal Brasileiro de Pneumologia;sep2009, Vol. 35 Issue 9, p920
Coccidioidomycosis is a systemic mycosis caused by the dimorphic fungi Coccidioides immitis and Coccidioides posaclasii. Infection is acquired by inhalation of infective arthroconidia that live in the soil. In 60% of cases, the infection is benign and resolves spontaneously. In the northern...
- A Therapeutic Dilemma. Sanford, William G.; Rasch, James R.; Stonehill, Robert B. // Annals of Internal Medicine;Apr62, Vol. 56 Issue 4, p553
Presents case reports on the treatment of disseminated coccidioidomycosis with amphotericin B. Importance of the coccidioidomycosis complement fixation test in diagnosing the disseminated form; Finding that the complement fixation titer is low in the majority of patients who recover.
- An Epidemic of Coccidioidomycosis in Arizona Associated with Climatic Changes, 1998-2001. Park, Benjamin J.; Siqel, Keith; Vaz, Victorio; Komatsu, Ken; McRill, Cheryl; Phelan, Maureen; Colman, Timothy; Comrie, Andrew C.; Warnock, David W.; Galgiani, John N.; Hajjeh, Rana A. // Journal of Infectious Diseases;6/1/2005, Vol. 191 Issue 11, p1981
Background. Reports of coccidioidomycosis cases in Arizona have increased substantially. We investigated factors associated with the increase. Methods. We analyzed the National Electronic Telecommunications System for Surveillance (NETSS) data from 1998 to 2001 and used Geographic Information...
- Primary Cutaneous Coccidioidomycosis. Goodman, Daniel H.; Schabarum, Bruno // Annals of Internal Medicine;Jul63 Part 1, Vol. 59 Issue 1, p84
Details a case of a 22-year-old man diagnosed with naturally acquired primary cutaneous coccidioidomycosis. Differentiation between primary cutaneous coccidioidomycosis and disseminated coccidioidomycosis with cutaneous manifestations; Presenting signs and symptoms; Past medical history;...
- valley fever. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2433
A reference entry for "valley fever" is presented.
- New Agents for Treatment of Invasive Aspergillosis. Patterson, Thomas F. // Clinical Infectious Diseases;8/15/2002, Vol. 35 Issue 4, p367
Editorial. Reports results of a study regarding treatment of invasive aspergillosis. Lipid formulation of amphotericin B; Assessment of the treatment's efficacy; Reason for slow patient accrual.